Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

被引：313

作者：

Powles, T. ^{[1
]}

Bellmunt, J. ^{[2
]}

Comperat, E. ^{[3
]}

De Santis, M. ^{[4
]}

Huddart, R. ^{[5
]}

Loriot, Y. ^{[6
,7
]}

Necchi, A. ^{[8
]}

Valderrama, B. P. ^{[9
]}

Ravaud, A. ^{[10
,11
]}

Shariat, S. F. ^{[12
]}

Szabados, B. ^{[1
,13
]}

van der Heijden, M. S. ^{[14
]}

Gillessen, S. ^{[15
]}

机构：

[1] Queen Mary Univ London, Barts Canc Ctr, Barts Hlth NHS Trust, London, England

[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, IMIM Lab, Boston, MA 02115 USA

[3] Hop Tenon, Assistance Publ Hop Paris, Paris, France

[4] Charite, Dept Urol, Berlin, Germany

[5] Royal Marsden Hosp, Inst Canc Res, London, England

[6] Univ Paris Saclay, Dept Med Oncol, Villejuif, France

[7] Gustave Roussy, Villejuif, France

[8] Univ Vita Salute San Raffaele, IRCCS San Raffaele Hosp, Dept Med Oncol, Milan, Italy

[9] Univ Hosp Virgen del Rocio, Seville, Spain

[10] Hop St Andre CHU, Bordeaux, France

[11] Bordeaux Univ Hosp, Dept Med Oncol, Bordeaux, France

[12] Med Univ Vienna, Vienna Gen Hosp, Dept Urol, Vienna, Austria

[13] Univ Coll London Hosp, Dept Urol, London, England

[14] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands

[15] EOC, Oncol Inst Southern Switzerland IOSI, Lugano, Switzerland

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 03期

关键词：

immune checkpoint inhibitors; fibroblast growth factor receptor inhibitors; antibody drug conjugates; bladder cancer; urothelial carcinoma; platinum-based chemotherapy; METASTATIC UROTHELIAL CARCINOMA; BACILLUS-CALMETTE-GUERIN; PHASE-III TRIAL; TRANSITIONAL-CELL CARCINOMA; COMBINED-MODALITY TREATMENT; RADICAL CYSTECTOMY; OPEN-LABEL; SINGLE-ARM; ADJUVANT CHEMOTHERAPY; PREDICTING RECURRENCE;

D O I：

10.1016/j.annonc.2021.11.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：244 / 258

页数：15

共 50 条

[21] Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Glimelius, B.
Pahlman, L.
Cervantes, A.
ANNALS OF ONCOLOGY, 2010, 21 : v82 - v86
[22] Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cascinu, S.
Falconi, M.
Valentini, V.
Jelic, S.
ANNALS OF ONCOLOGY, 2010, 21 : v55 - v58
[23] Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Filetti, S.
Durante, C.
Hartl, D.
Leboulleux, S.
Locati, L. D.
Newbold, K.
Papotti, M. G.
Berruti, A.
ANNALS OF ONCOLOGY, 2019, 30 (12) : 1856 - 1883
[24] Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Marth, C.
Landoni, F.
Mahner, S.
McCormack, M.
Gonzalez-Martin, A.
Colombo, N.
ANNALS OF ONCOLOGY, 2017, 28 : 72 - 83
[25] Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Rao, S.
Guren, M. G.
Khan, K.
Brown, G.
Renehan, A. G.
Steigen, S. E.
Deutsch, E.
Martinelli, E.
Arnold, D.
ANNALS OF ONCOLOGY, 2021, 32 (09) : 1087 - 1100
[26] Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Colombo, N.
Preti, E.
Landoni, F.
Carinelli, S.
Colombo, A.
Marini, C.
Sessa, C.
ANNALS OF ONCOLOGY, 2011, 22 : vi35 - vi39
[27] Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Pacini, F.
Castagna, M. G.
Brilli, L.
Pentheroudakis, G.
ANNALS OF ONCOLOGY, 2010, 21 : v214 - v219
[28] Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Stahl, M.
Mariette, C.
Haustermans, K.
Cervantes, A.
Arnold, D.
ANNALS OF ONCOLOGY, 2013, 24 : 51 - 56
[29] Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Glynne-Jones, R.
Wyrwicz, L.
Tiret, E.
Brown, G.
Rodel, C.
Cervantes, A.
Arnold, D.
ANNALS OF ONCOLOGY, 2017, 28 : 22 - 40
[30] Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Horwich, A.
Parker, C.
Bangma, C.
Kataja, V.
ANNALS OF ONCOLOGY, 2010, 21 : v129 - v133

← 1 2 3 4 5 →